AXA IM and BNPP AM are progressively merging and streamlining our legal entities to create a unified structure. Whilst this is ongoing, we will continue to operate two seperate websites both branded BNPP AM. Learn more. 

Alanna Green

Investment Analyst of Healthcare Private Equity
AXA IM Alts is part of the BNP Paribas Group

Joining the AXA IM Alts team in 2024, Alanna brings experience that sits at the intersection of investments and life sciences. Alanna previously spent two years at Eccleston Associates as an Investment Consultant, working on pan-European M&A transactions, corporate due diligence and strategy/transformation projects across multiple industries including Pharmaceuticals and Healthcare, Business Services and Software.

Alanna also worked at Eye2Gene and Dawn Pharma, two MedTech start-ups with a focus on artificial intelligence, diagnostics, and precision medicine.

Alanna holds an Msc in Bioscience Entrepreneurship from University College London, and a BSc in Cellular and Molecular Medicine from The University of Bristol.

    AXA IM and BNPP AM are progressively merging

    AXA IM and BNPP AM are progressively merging and streamlining our legal entities to create a unified structure

    AXA Investment Managers joined BNP Paribas Group in July 2025. Following the merger of AXA Investment Managers Paris and BNP PARIBAS ASSET MANAGEMENT Europe and their respective holding companies on December 31, 2025, the combined company now operates under the BNP PARIBAS ASSET MANAGEMENT Europe name.